Stay updated on TRuE AD1 Clinical Trial
Sign up to get notified when there's something new on the TRuE AD1 Clinical Trial page.

Latest updates to the TRuE AD1 Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed; no substantive changes to core content, pricing, stock, or time-slot information.SummaryDifference0.1%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility names and locations across Germany and Poland, as well as new research references related to Ruxolitinib cream for atopic dermatitis. Notably, previous location terms and related topics have been removed.SummaryDifference4%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.3%
Stay in the know with updates to TRuE AD1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TRuE AD1 Clinical Trial page.